VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Why the 2026 IPO Window Is Splitting in Two
Value Add VC/Pulse/IPO

Why the 2026 IPO Window Is Splitting in Two

2026's IPO market is really two separate markets moving in opposite directions at once: trillion-dollar AI-infrastructure names commanding record multiples, and everything else -- from Jersey Mike's to micro-cap S-1 filers -- pricing on old-fashioned fundamentals.

TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 29, 2026
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

US IPOs have raised $251 billion across 86 deals in 2026 through late July, already surpassing all of 2025's roughly $47.4 billion full-year total -- but that headline number is overwhelmingly concentrated in a handful of AI-infrastructure and mega-cap names

2

SpaceX alone represented roughly a third of every dollar raised in US IPOs this year at its $1.75 trillion pricing, meaning the 'average' 2026 IPO story is wildly distorted by a handful of outliers rather than reflecting the median issuer's experience

3

Jersey Mike's pricing this week at up to a $7.9 billion valuation -- a boring, profitable, understandable sandwich chain -- landed the same week as a $1 trillion-plus AI chip-stock selloff, giving public investors a live comparison between AI-narrative risk and old-economy cash flow

4

Fintech names like Plaid ($8 billion valuation, early bank talks) and wearables maker Oura ($11 billion, confidentially filed) sit in between -- growth stories without the AI-infrastructure capex intensity that's currently drawing investor skepticism

TC

The VC Read · Trace's Take

Trace Cohen

Stop reading 2026 IPO news as one market -- it's two, and they're diverging fast. The AI-infrastructure names are getting priced on a capex-to-returns promise that's under real pressure right now; everything else is still getting priced the old-fashioned way, on margin and understandable growth. If your company isn't genuinely AI-infrastructure scale, the Jersey Mike's comp is more useful to you than the SpaceX one -- boring and profitable is trading well this week for a reason.

Tech IPO Tracker → IPO Market 2026 Analysis →

Analysis

2026 has been framed as the biggest IPO year in a decade, and by the topline numbers it is: US IPOs have raised roughly $251 billion across 86 deals through late July, comfortably surpassing 2025's full-year total of about $47.4 billion. But that headline obscures a market that is really splitting into two very different regimes, and this week's news cycle put both on display simultaneously.

On one side sits AI-infrastructure-scale issuance, led overwhelmingly by SpaceX's record $1.75 trillion pricing, which alone accounted for roughly a third of every dollar raised in US IPOs this year. Anthropic and OpenAI are both reportedly working through confidential S-1 processes at similarly outsized prospective valuations. These are the names driving the eye-popping topline dollar figure, and they're also the names most exposed to exactly the kind of sentiment swing this week's chip-stock selloff represents -- a market questioning whether AI infrastructure capex is outrunning actual demand.

On the other side sits everything else: Jersey Mike's pricing this week at up to a $7.9 billion valuation for a 70-year-old, 3,300-location sandwich chain with a knowable, understandable margin profile; a steady background rate of smaller S-1 filers across biotech, land, power systems and crypto; and growth-but-not-AI-infrastructure names like fintech data network Plaid, which reached an $8 billion valuation and has held early talks with banks about a potential listing, and wearables maker Oura, which confidentially filed at an $11 billion mark built on genuine consumer revenue growth rather than infrastructure capex.

“Anthropic and OpenAI are both reportedly working through confidential S-1 processes at similarly outsized prospective valuations.”

The distinction that matters for anyone pricing risk right now is capital intensity. AI-infrastructure names are being underwritten on the promise that massive, ongoing capex converts into proportional future returns -- exactly the promise this week's chip-stock selloff is calling into question. Jersey Mike's, Plaid and Oura are underwritten on more traditional growth-and-margin stories that don't depend on that same capex-to-return conversion holding up. In a week when SK Hynix posted record profit and still got punished 10% for merely growing instead of re-accelerating, the market's preference for the second group over the first is becoming harder to ignore.

For founders and GPs thinking about exit timing over the next 12 months, the practical read is: don't assume the 2026 mega-IPO window's multiples apply to your company if your growth story isn't genuinely AI-infrastructure-scale. A clean, profitable, understandable business -- the Jersey Mike's model -- may find a friendlier public-market reception right now than a capital-intensive AI story competing for the same investor dollars as SpaceX, Anthropic and the chip names currently under pressure.

What to watch: whether Plaid and Oura's IPO processes, if they proceed, get priced on AI-infrastructure-style multiples or on more traditional growth-company benchmarks, and whether the current chip-sector selloff bleeds into softer reception for the AI-infrastructure mega-IPOs still in the pipeline behind SpaceX.

ShareXLinkedInEmail

More on

Jersey Mike's →

Reported by Value Add Pulse Analysis · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com